longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Tech and Health Microcaps Pivot: QuickLogic Surges on AI, Aterian Pushes Asset Sale

Global Report
Aug 29, 2026 at 10:12 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Small-cap firms are accelerating strategic pivots in 2026. QuickLogic is capitalizing on AI data center demands with surging revenue, while Aterian pushes through a critical asset sale to restructure. Operational efficiency is dominating the agenda.

A mix of strategic acquisitions, clinical milestones, and defensive divestitures are driving momentum across specialized tech and healthcare microcaps in 2026 as companies navigate an unforgiving capital environment.

In the semiconductor space, QuickLogic Corporation (QUIK.US) is successfully riding the artificial intelligence wave. The fabless chipmaker posted a 48.7% revenue jump to $5.5 million in its 2026 second quarter, prompting CEO Brian Faith to forecast an aggressive 70% to 80% full-year growth rate. The momentum was further bolstered by a new partnership with PQSecure for post-quantum cryptography integration. Meanwhile, Dragonfly Energy Holdings Corp. (DFLI.US) is advancing its own technology stack, embedding AI into its battery architecture via a Sphere Energy tie-up and expanding its market footprint through a recent acquisition of Dakota Lithium assets.

Healthcare and biotech players are equally active on the operational front. Tonix Pharmaceuticals Holding Corp. (TONX.US) reported better-than-expected Q2 2026 financial results and secured favorable FDA feedback regarding its phase 2 study design for a Lyme disease antibody. Xtant Medical Holdings, Inc. (XBCI.US) is also expanding its commercial reach, inking an exclusive distribution deal with Henry Schein’s BioHorizons for its allograft technology. This follows Xtant's strong first-quarter revenue guidance hike to over $100 million for the full year.

Corporate restructuring and targeted capital allocation remain dominant themes elsewhere. Aterian, Inc. (ATER.US) has issued an urgent proxy plea to shareholders to secure an $18 million sale of its flagship brands—a divestiture critical to its broader turnaround strategy. Flexsteel Industries (FLX.US) highlighted record EPS in its fiscal 2026 results, though recent insider selling of over $460,000 in stock by a top executive has drawn market scrutiny. The Taiwan Fund, Inc. (TWN.US) continues to navigate regional market dynamics, recently reporting Q3 earnings and acknowledging a major stake held by City of London.

Across alternative data and software sectors, the focus on cost controls is sharpening. TON Strategy Company (UX.US) confirmed the wind-down of its legacy social commerce operations to reduce baseline expenses. Broadly, companies including WM Technology, Inc. (MAPS.US) and specialized market instruments like HIBS (HIBS.US) are maneuvering through 2026's heightened volatility by prioritizing liquidity and core operations.

Login to unlock1,983characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

TON Strategy

TON Strategy

USTONX

+9.35%

BingEx

BingEx

USFLX

-20.78%

QuickLogic

QuickLogic

USQUIK

+1.90%

LongbridgeAI